Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis

被引：0
作者：
Fardin Dolatimehr
Hamidreza Karimi-Sari
Mohammad Saeid Rezaee-Zavareh
Seyed Moayed Alavian
Bita Behnava
Mohammad Gholami-Fesharaki
Heidar Sharafi
机构：
[1] Student Research Committee,Baqiyatallah Research Center for Gastroenterology and Liver Diseases (BRCGL)
[2] Baqiyatallah University of Medical Sciences,Department of Biostatistics, Faculty of Medical Sciences
[3] Meta-analysis Study Group,undefined
[4] Iran Hepatitis Network,undefined
[5] Baqiyatallah University of Medical Sciences,undefined
[6] Middle East Liver Disease (MELD) Center,undefined
[7] Tarbiat Modares University,undefined
来源：
DARU Journal of Pharmaceutical Sciences | / 25卷
关键词：
Hepatitis C; Sofosbuvir; Ribavirin; Pegylated-interferon; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[31]   Retinal vein thrombosis associated with pegylated-interferon and ribavirin combination therapy for chronic hepatitis C [J].
Iman Zandieh ;
Mohamed Adenwalla ;
Cindy Cheong-Lee ;
Patrick E Ma ;
Eric M Yoshida .
World Journal of Gastroenterology, 2006, (30) :4908-4910
[32]   Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [J].
Qiu-Feng He ;
Qiong-Fang Zhang ;
Da-Zhi Zhang .
Digestive Diseases and Sciences, 2016, 61 :3108-3117
[33]   Boceprevir and telaprevir for chronic genotype 1 hepatitis C virus infection. A systematic review and meta-analysis [J].
Manzano-Robleda, Maria del Carmen ;
Ornelas-Arroyo, Victoria ;
Barrientos-Gutierrez, Tonatiuh ;
Mendez-Sanchez, Nahum ;
Uribe, Misael ;
Chavez-Tapia, Norberto C. .
ANNALS OF HEPATOLOGY, 2015, 14 (01) :46-57
[34]   Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection [J].
Saab, S. ;
Gordon, S. C. ;
Park, H. ;
Sulkowski, M. ;
Ahmed, A. ;
Younossi, Z. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) :657-675
[35]   Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies [J].
Xirouchakis, E. ;
Triantos, C. ;
Manousou, P. ;
Sigalas, A. ;
Calvaruso, V. ;
Corbani, A. ;
Leandro, G. ;
Patch, D. ;
Burroughs, A. .
JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) :699-709
[36]   HCV core antigen is a useful predictor during pegylated-interferon/ribavirin therapy in patients with hepatitis C virus genotype 1b [J].
Fan, Zhijuan ;
Liu, Junfeng ;
Wang, Fengmei ;
Liu, Jingmin ;
Ding, Xian ;
Liu, Shuye .
MEDICINE, 2019, 98 (10)
[37]   Ledipasvir and sofosbuvir:Interferon free therapy for hepatitis C virus genotype 1 infection [J].
Yasir Waheed .
World Journal of Virology, 2015, (01) :33-35
[38]   The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis [J].
Hung, Hsuan-Yu ;
Lai, Hui-Hsiung ;
Lin, Hui-Chuan ;
Chen, Chung-Yu .
ANNALS OF MEDICINE, 2023, 55 (01) :463-479
[39]   Meta-analysis of patients with hepatitis C virus genotype 6: 48 weeks with pegylated interferon and ribavirin is superior to 24 weeks [J].
Nguyen, Nghia H. ;
McCormack, Shelley A. ;
Yee, Brittany E. ;
Devaki, Pardha ;
Jencks, David ;
Chao, David T. ;
Nguyen, Mindie H. .
HEPATOLOGY INTERNATIONAL, 2014, 8 (04) :540-549
[40]   Simeprevir with pegylated interferon alfa 2a plus ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a meta-analysis and historical comparison [J].
Frank Andersohn ;
Anne-Kathrin Claes ;
Werner Kulp ;
Jörg Mahlich ;
Jürgen Kurt Rockstroh .
BMC Infectious Diseases, 16
12345